Aspergillosis research is evolving rapidly, including the development of new antifungal medicines, biologic treatments, diagnostic tests, monitoring approaches and ways to improve respiratory health and quality of life.
Research findings do not necessarily mean that a new test or treatment is ready for routine clinical use. Studies may be at very different stages, from laboratory and animal research through clinical trials to evidence that could influence future guidelines and patient care.
This hub brings together recent aspergillosis research and explains what new findings may mean for patients, carers and healthcare professionals. We aim to distinguish promising early research from developments that are closer to changing clinical practice.
Research to Watch
These selected developments may be especially interesting or potentially important for people with aspergillosis and for anyone wanting to understand how care may change.
Each article explains what is new, why it might matter, how close it may be to clinical use, and what remains uncertain.
Topics in This Hub
Latest Research Articles
Weekly Aspergillosis Research Update – 5 October 2026
October 5, 2026
Hope on the horizon: Novel antifungal treatments in development
September 17, 2026
This Week in Aspergillosis Research: Dupilumab and ABPA
September 14, 2026
European Aspergillosis PAG at ERS 2026: from patient to partner
September 8, 2026
Weekly Aspergillosis Research Update – 24 August 2026
August 24, 2026
Weekly Aspergillosis Research Update: June 29
June 29, 2026
Weekly Aspergillosis Research Update – 15 June 2026
June 15, 2026
Professional Aspergillosis Update: May 2026
June 9, 2026
Did this page help you?
Tell us in one minute































